Minitaller sobre la aceptación y el uso de las vacunas en el contexto de la seguridad de las mismas
Date:
22/04/2021
Entender cómo piensa, se posiciona y actúa la gente sobre la vacunación es fundamental para informar el desarrollo de estrategias para la aceptación y el uso de las vacunas. La generación y el uso de datos sobre los factores sociales y de comportamiento implicados requiere un conjunto de herramientas -encuestas, guías de entrevistas, herramientas y marcos relacionados- para apoyar la recopil...
See more details
Betacoronavirus/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Viral Vaccines/supply & distribution, Immunization Programs/organization & administration, Access to Essential Medicines and Health Technologies, Health Equity, Viral Vaccines/adverse effects, Health Communication, Communication, Health Systems/organization & administration, Social Participation, Vaccine Potency, Risk Groups, Quarantine, Social Isolation, COVID-19, Infodemia
Cities hold the key: prioritizing equity in the COVID-19 recovery
Date:
16/04/2021
Cities were at the epicentre of the COVID-19 outbreak and have mounted a remarkable response. Urban centres now face the challenge of vaccine distribution. Speakers will highlight their response to the pandemic, steps to ensure equitable vaccine distribution and recovery, and how their policies can serve as models for governments and regions worldwide.
See more details
Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Immunization Programs/organization & administration, Viral Vaccines/supply & distribution, Betacoronavirus/immunology, Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Epidemiological Monitoring, Local Health Systems/organization & administration, Access to Essential Medicines and Health Technologies, Health Equity, Urban Health, 34658, Risk Groups, Health Communication, COVID-19
WHO SAGE presenting its interim recommendations on the use of AstraZeneca Vaccine against COVID-19
Date:
10/02/2021
See more details
Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Pneumonia, Viral/prevention & control, Viral Vaccines/immunology, Betacoronavirus/immunology, Epidemiological Monitoring, Health Communication, Viral Vaccines/supply & distribution, Vaccine Potency, Betacoronavirus/genetics, Mutation/genetics, DNA, Viral/genetics, Coronavirus Infections/genetics, Pneumonia, Viral/genetics, Risk Groups, COVID-19, AstraZeneca, Oxford
Live Q&A on tuberculosis with Tereza Kasaeva in time of COVID-19. Ask WHO on how to end TB!
Date:
23/03/2021
See more details
Pneumonia, Viral/prevention & control, Coronavirus Infections/prevention & control, Pandemics/prevention & control, Epidemiological Monitoring, Americas/epidemiology, Tuberculosis/epidemiology, Vulnerable Populations, Health Communication, Tuberculosis/prevention & control, Triage, Risk Groups, Health Services Accessibility, Health Human Resource Training, Health Personnel/education, COVID-19
Live Q&A on COVID-19 with Dr Mike Ryan and Dr Maria Van Kerkhove
Date:
31/03/2021
See more details
Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/statistics & numerical data, Epidemiological Monitoring, Americas/epidemiology, Health Communication, Risk Groups, Immunization Programs/organization & administration, Betacoronavirus/immunology, Coronavirus Infections/immunology, Viral Vaccines/supply & distribution, Pneumonia, Viral/immunology, Antiviral Agents/therapeutic use, COVID-19
Media briefing on COVID-19 - 26/03/2021
Date:
26/03/2021
00:00:18
CL Hello. Good day to... wherever you are listening to us. Today is Friday 26th March 2021. My name is Christian Lindmeier and I'm welcoming you to today's global COVID-19 press conference. Simultaneous interpretation is provided in the six official UN languages, Arabic, Chinese, French, English, Spanish and Russian, as well as Portuguese and Hindi.
The participants today are, p...
See more details
Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Viral Vaccines/supply & distribution, Immunization Programs/organization & administration, Health Communication, Risk Groups, Health Equity, Hospital Bed Capacity, Intensive Care Units, Americas/epidemiology, Betacoronavirus/genetics, Coronavirus Infections/genetics, Pneumonia, Viral/genetics, Viral Vaccines/immunology, Vaccine Potency, Mutation/genetics, DNA, Viral/genetics, COVID-19, Ghebreyesus, Tedros Adhanom , Covax
COVID-19 live Q&A with Dr Mike Ryan and Dr Maria Van Kerkhove. Ask WHO of 6 January 2021
Date:
06/01/2021
#AskWHO series: This was the live discussion about the COVID-19 pandemic of 6 January 2021 with Dr Mike Ryan, Executive Director of WHO Health Emergencies Programme, and Dr Maria Van Kerkhove, WHO Technical Lead on COVID-19. Questions from the audience were taken.
See more details
Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Social Isolation, Quarantine, Pandemics/prevention & control, Epidemiological Monitoring, Health Communication, Holidays, Americas/epidemiology, Risk Groups, Betacoronavirus/immunology, Viral Vaccines/immunology, Immunization Programs/organization & administration, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Masks, Betacoronavirus/genetics, Pneumonia, Viral/genetics, Coronavirus Infections/genetics, DNA, Viral/genetics, Mutation/genetics, Vaccine Potency, COVID-19
¿Por qué se definen grupos prioritarios para vacunarse?
Date:
15/03/2021
Dr. Giovanni Escalante. Representante de OPS/OMS en Uruguay. Médico. Mágister en Salud Pública en los Países en Desarrollo por la Escuela de Higiene y Medicina Tropical de Londres (Reino Unido), y en Gerencia Social por la Pontificia Universidad Católica del Perú. Diplomado en Gestión de Salud Pública por la Universidad Nacional Autónoma de México. Especialización en Administración de...
See more details
Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Pandemics/prevention & control, Viral Vaccines/immunology, Health Communication, Risk Groups, COVID-19
Guyana journalists and health communicators workshop: responsible reporting on the COVID-19 pandemic
Date:
24/11/2020
PAHO/WHO Guyana - Training for journalists and health communicators: Responsible reporting on the COVID-19 Pandemic
See more details
Health Communication, Journalism/organization & administration, Health Information Management/organization & administration, Pandemics/prevention & control, Online Social Networking, Vulnerable Populations, Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Epidemiological Monitoring, Hand Disinfection, Social Isolation, Masks, Health Promotion, Risk Groups, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Betacoronavirus/immunology, Coronavirus Infections/transmission, Pneumonia, Viral/transmission, Viral Vaccines/immunology, Social Stigma, COVID-19, Fake news, Infodemia
live from UNGA side event on infodemic management with Dr Tedros
Date:
23/09/2020
See more details
Coronavirus Infections/transmission, Coronavirus Infections/diagnosis, Coronavirus Infections/epidemiology, Pneumonia, Viral/transmission, Pneumonia, Viral/diagnosis, Pneumonia, Viral/epidemiology, Pandemics/prevention & control, Communication, Health Promotion, Online Social Networking, News, Health Communication, Health Information Management/organization & administration, Self Medication/adverse effects, Health Personnel/organization & administration, Risk Groups, Health Systems/organization & administration, COVID-19, Ghebreyesus, Tedros Adhanom , Infodemia, Fake news
